OA12.06 Neoadjuvant Durvalumab + Chemotherapy Followed by Adjuvant Durvalumab in Resectable EGFR-mutated NSCLC (AEGEAN)

J. He, S. Gao,M. Reck, D. Harpole, T. Mitsudomi, J.M. Taube, K.-Y. Lee,Y. Horio, Y. Runglodvatana, M. Aperghis,G.J. Doherty, P.J. Laud,T.M. Fouad,J.V. Heymach

Journal of Thoracic Oncology(2023)

引用 0|浏览7
暂无评分
关键词
neoadjuvant durvalumab,chemotherapy,nsclc,egfr-mutated
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要